Does Electronic Monitoring Influence Adherence to Medication? Randomized Controlled Trial of Measurement Reactivity

Annals of Behavioral Medicine

Volumn 48, Issue 3, 2014, Pages 293-299

  Sutton, Stephen ^a   Kinmonth, Ann Louise ^a   Hardeman, Wendy ^a   Hughes, Dyfrig ^b   Boase, Sue ^a   Prevost, A Toby ^c   Kellar, Ian ^a   Graffy, Jonathan ^a   Griffin, Simon ^a   Farmer, Andrew ^d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b BANGOR UNIVERSITY   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Diabetes; Electronic monitoring; Measurement reactivity; Medication adherence

Indexed keywords

EID: 84894247087     PISSN: 08836612     EISSN: 15324796     Source Type: Journal    
DOI: 10.1007/s12160-014-9595-x     Document Type: Article

References (23)

1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353: 487-97.
2. Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006; 43: S70-87.
3. Greenlaw SM, Yentzer BA, O’Neill JL, Balkrishnan R, Feldman SR. Assessing adherence to dermatology treatments: A review of self-report and electronic measures. Skin Res Technol. 2010; 16: 253-258.
4. Saini SD, Schoenfeld P, Kaulback K, Dubinsky MC. Effect of medication dosing frequency on adherence in chronic diseases. Am J Manag Care. 2009; 15: e22-e33.
5. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: Longitudinal study of electronically compiled dosing histories. Br Med J. 2008; 336: 1114-1117.
6. Gerin W, Tobin JN, Schwartz JE, Chaplin W, Rieckmann N, et al. The medication Adherence and Blood Pressure Control (ABC) trial: A multi-site randomized controlled trial in a hypertensive, multi-cultural, economically disadvantaged population. Contemp Clin Trials. 2007; 28: 459-71.
7. Zeller A, Schroeder K, Peters TJ. An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment. J Clin Epidemiol. 2008; 61: 282-8.
8. French DP, Sutton S. Reactivity of measurement in health psychology: How much of a problem is it? What can be done about it? Br J Health Psychol. 2010; 15: 453-68.
9. McCambridge J, Butor-Bhavsar K, Witton J, Elbourne D. Can research assessments themselves cause bias in behaviour change trials? A systematic review of evidence from Solomon 4-group studies. PloS One. 2011; 6: e25223.
10. Denhaerynck K, Schäfer-Keller P, Young J, Steiger J, Bock A, De Geest S. Examining assumptions regarding valid electronic monitoring of medication therapy: Development of a validation framework and its application on a European sample of kidney transplant patients. BMC Med Res Methodol. 2008; 8: 5.
11. Cramer JA, Ouellette VL, Mattson RH. Effect of microelectronic observation on compliance. Epilepsia. 1990; 31: 617-618.
12. Matsui D, Hermann C, Klein J, Berkovitch M, Olivieri N, Koren G. Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator. J Clin Pharmacol. 1994; 34: 944-949.
13. Yeung M, O’Connor SA, Parry DT, Cochrane GM. Compliance with prescribed drug therapy in asthma. Respir Med. 1994; 88: 31-35.
14. Bertholet N, Favrat B, Fallab-Stubi CL, Brunner HR, Burnier M. Why objective monitoring of compliance is important in the management of hypertension. J Clin Hypertens (Greenwich). 2000; 2: 258-262.
15. Elixhauser A, Eisen SA, Romeis JC, Homan SM. The effects of monitoring and feedback on compliance. Med Care. 1990; 28: 882-93.
16. Wagner GJ, Ghosh-Dastidar B. Electronic monitoring: Adherence assessment or intervention? HIV Clin Trials. 2002; 3: 45-51.
17. Farmer A, Hardeman W, Hughes D, et al. An explanatory randomised controlled trial of a nurse-led, consultation-based intervention to support patients with adherence to taking glucose lowering medication for type 2 diabetes. BMC Fam Pract. 2012; 13: 30.
18. Mora P, Berkowitz A, Contrada RJ, et al. Factor structure and longitudinal invariance of the Medication Adherence Report Scale—Asthma. Psychol Health. 2011; 26: 713-727.
19. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986; 24: 67-74.
20. Farmer AJ, Prevost AT, Hardeman W, et al. for The Support and Advice for Medication Trial Group. Protocol for SAMS (Support and Advice for Medication Study): A randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication. BMC Fam Pract. 2008; 9: 20.
21. White IR, Thompson SG. Adjusting for partially missing baseline measurements in randomized trials. Stat Med. 2005; 24: 993-1007.
22. Deschamps AE, Van Wijngaerden E, Denhaerynck K, Vandamme A-M, De Geest S. Use of electronic monitoring induces a 40-day intervention effect in HIV patients. J Acquir Immune Defic Syndr. 2006; 43: 247-249.
23. Cohen JL, Mann DM, Wisnivesky JP, et al. Assessing the validity of self-reported medication adherence among inner-city asthmatic adults: The Medication Adherence Report Scale for Asthma. Ann Allergy Asthma Immunol. 2009; 103: 325-331.